Early mortality and loss to follow-up in HIV-infected children starting antiretroviral therapy in Southern Africa. - Wikidata - wikimedia - TriplyDB

Early mortality and loss to follow-up in HIV-infected children starting antiretroviral therapy in Southern Africa.

Early mortality and loss to follow-up in HIV-infected children starting antiretroviral therapy in Southern Africa.

http://www.wikidata.org/entity/Q34077664

about

Optimal time for initiating antiretroviral therapy (ART) in HIV-infected, treatment-naive children aged 2 to 5 years old When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern Africa Survival Outcomes in a Pediatric Antiretroviral Treatment Cohort in Southern Malawi BUILDING NEW KNOWLEDGE Growth and Mortality Outcomes for Different Antiretroviral Therapy Initiation Criteria in Children Ages 1-5 Years: A Causal Modeling Analysis Predictors of mortality among HIV infected children on anti-retroviral therapy in Mekelle Hospital, Northern Ethiopia: a retrospective cohort study HIV-infected children in rural Zambia achieve good immunologic and virologic outcomes two years after initiating antiretroviral therapy The impact of HIV on children's education in eastern Zimbabwe The effect of highly active antiretroviral therapy on the survival of HIV-infected children in a resource-deprived setting: a cohort study Risk factors associated with increased mortality among HIV infected children initiating antiretroviral therapy (ART) in South Africa Treatment outcomes among HIV-1 and HIV-2 infected children initiating antiretroviral therapy in a concentrated low prevalence setting in West Africa.Poor clinical outcomes for HIV infected children on antiretroviral therapy in rural Mozambique: need for program quality improvement and community engagement Increases in pediatric antiretroviral treatment, South Africa 2005-2010.Early loss to follow-up of recently diagnosed HIV-infected adults from routine pre-ART care in a rural district hospital in Kenya: a cohort study Viral load versus CD4⁺ monitoring and 5-year outcomes of antiretroviral therapy in HIV-positive children in Southern Africa: a cohort-based modelling study Mortality among adults transferred and lost to follow-up from antiretroviral therapy programmes in South Africa: a multicenter cohort study Antiretroviral treatment program retention among HIV-infected children in the Democratic Republic of Congo Paediatric HIV care in sub-Saharan Africa: clinical presentation and 2-year outcomes stratified by age group.Virologic failure and second-line antiretroviral therapy in children in South Africa--the IeDEA Southern Africa collaboration.Temporal trends in the characteristics of children at antiretroviral therapy initiation in southern Africa: the IeDEA-SA Collaboration Tuberculosis in HIV programmes in lower-income countries: practices and risk factors Prognosis of children with HIV-1 infection starting antiretroviral therapy in Southern Africa: a collaborative analysis of treatment programs Tuberculosis in Pediatric Antiretroviral Therapy Programs in Low- and Middle-Income Countries: Diagnosis and Screening Practices.Hospital admissions from a pediatric HIV care and treatment program in Malawi.Growth of HIV-Exposed Uninfected Infants in the First 6 Months of Life in South Africa: The IeDEA-SA Collaboration.Delayed entry into HIV care after diagnosis in two specialized care and treatment centres in Cameroon: the influence of CD4 count and WHO staging.Implementation and Operational Research: Early Tracing of Children Lost to Follow-Up From Antiretroviral Treatment: True Outcomes and Future Risks.Implementation and Operational Research: Risk Factors of Loss to Follow-up Among HIV-Positive Pediatric Patients in Dar es Salaam, Tanzania.Cohort Profile: the international epidemiological databases to evaluate AIDS (IeDEA) in sub-Saharan Africa.Clinical decision tools are needed to identify HIV-positive patients at high risk for poor outcomes after initiation of antiretroviral therapy.Mortality in the year following antiretroviral therapy initiation in HIV-infected adults and children in Uganda and Zimbabwe.Outcomes of antiretroviral therapy in children in Asia and Africa: a comparative analysis of the IeDEA pediatric multiregional collaboration.Predictors of loss to follow-up among children in the first and second years of antiretroviral treatment in Johannesburg, South Africa.The contribution of schools to supporting the well being of children affected by HIV in eastern Zimbabwe Participation and retention of youth with perinatal HIV infection in mental health research studies: the IMPAACT P1055 psychiatric comorbidity study Baseline Inflammatory Biomarkers Identify Subgroups of HIV-Infected African Children With Differing Responses to Antiretroviral Therapy.Survival benefit of early infant antiretroviral therapy is compromised when diagnosis is delayed.Anaemia and zidovudine-containing antiretroviral therapy in paediatric antiretroviral programmes in the IeDEA Paediatric West African Database to evaluate AIDS.[Treatment failure in children infected with HIV in routine follow-up in a resource-limited setting in Cameroon]High retention among HIV-infected children in Rwanda during scale-up and decentralization of HIV care and treatment programs, 2004 to 2010.

P2860

Q24197527-1BBEE32A-96EA-4623-86A2-5D518EDD2797 Q28535251-217B8157-9576-4BDE-91BA-7EDF72C1B1EB Q28553184-E6892AD1-1E7D-4F36-A554-9864D4D8C33D Q29248576-0E5CF440-1E18-4251-95FC-4350F43FFB1B Q33619587-8007B26F-1F84-4751-BFB8-E529A607D981 Q33640957-A2BF1B8E-8561-42F6-8332-0884F59586E5 Q33892515-0E5B6DDE-CBD7-46E5-8C53-22112C68BB52 Q33925426-6B08F151-355F-424D-A6FA-0EF9DFF380C2 Q33939293-82FA9217-1D7F-45A9-92F1-8A39CB13012C Q33987771-486E70AC-A3DD-4A20-84B8-FAD2C734EDE7 Q34329544-1CABE6A9-C5CB-432A-B107-8D622FE86796 Q34374033-9E6D0C54-9AD2-4575-90A0-C0232497654A Q34427645-D0B047E1-F669-4B40-8FB1-47B42575AB19 Q34503222-469F6911-85AD-4C0B-99AC-EDD35A901CBE Q34508454-80858B9C-70BD-453E-86AB-7AD496C80549 Q34551748-105B620A-720F-41FA-8922-1E90A3A4FEFC Q34775940-44F5744F-B796-4446-8CC5-45580CA572FF Q34843384-0EC2AB60-38C7-4504-8D6D-12957746C4E1 Q35014160-1CA62B07-342E-4EBD-AF61-CCEC0C3D499C Q35074354-AFB5C751-9E70-4589-9B98-D0FA10DE41B0 Q35117177-74BD41F0-72B2-497E-9ECD-0EABD41F85AE Q35148237-EF6E76AE-453E-48E7-ABDE-981910BF291A Q35788768-4FDE4446-C153-49E8-A392-B2E2AD284D88 Q35910124-34922F77-430B-4920-A60B-457ECC382767 Q35980844-BE9C49F7-AD80-4BD2-8954-1FA16456CAE2 Q36070839-828F5ED9-1186-436B-915D-CD149089E3BB Q36282732-942F439D-0F7C-4555-B884-9E6FA401AF4C Q36294353-BBEF0719-5C8D-4624-BDD9-00330C960FCF Q36301925-5ED6BF25-62B6-45C8-918F-DEA652812207 Q36349654-511D3F50-1BBB-4689-B9F2-25E079BFB6EB Q36408945-EB59991E-6DC6-4EAF-A2B4-E8E4CE37BFAE Q36565583-A61DCBAE-8DF1-4691-B4D0-4931707F5FC2 Q36566897-5EC561B1-55CB-4165-A5D1-3B3DCAB8381A Q36603245-0165325E-9FEE-4F81-9CB5-4CDDF8E17FF6 Q36930477-D983308A-CAA6-4AC6-BA3B-37E855D03595 Q37033083-A5B3275E-EB9F-4200-851D-304A61F2757F Q37131384-F62BB45D-E553-4D6E-A006-C82BF337D072 Q37182021-D1A3DB17-2D8E-4E80-B0CD-A6465E91EF22 Q37260613-35EFFFD8-D5D1-459D-83AB-0FEE7BB1C36A Q37343714-8E1D27D3-7FC5-45D1-A1E5-88CE6887D661

P2860

Early mortality and loss to follow-up in HIV-infected children starting antiretroviral therapy in Southern Africa.

http://www.wikidata.org/entity/Q34077664

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Early mortality and loss to fo ...... al therapy in Southern Africa.

@ast

Early mortality and loss to fo ...... al therapy in Southern Africa.

@en

Early mortality and loss to fo ...... al therapy in Southern Africa.

@nl

type

label

Early mortality and loss to fo ...... al therapy in Southern Africa.

@ast

Early mortality and loss to fo ...... al therapy in Southern Africa.

@en

Early mortality and loss to fo ...... al therapy in Southern Africa.

@nl

prefLabel

Early mortality and loss to fo ...... al therapy in Southern Africa.

@ast

Early mortality and loss to fo ...... al therapy in Southern Africa.

@en

Early mortality and loss to fo ...... al therapy in Southern Africa.

@nl

P1433

Q34077664-29044CA7-2E96-4AB3-90EC-3D513A742EA5

P1476

Q34077664-6B06DA3B-6323-4AF5-9C55-40ECB96322F1

P2093

Q34077664-01298699-405A-474E-B7C7-2DD6A7876F5F

Q34077664-092CA0A5-CF5B-40DB-B07F-E9D7626009D5

Q34077664-5EB0953B-B2E3-4E03-88D2-FB999D0E7234

Q34077664-78AC1D7D-0083-4399-B1F5-B20D06815C29

Q34077664-7D3176E5-46F2-408B-A05F-D35C0497F377

Q34077664-950EC0B9-8EA7-442E-B900-1BAEFD71C7C3

Q34077664-D5443D04-C4B2-43B6-97D6-8CEE664DA279

Q34077664-E10A90BD-D77D-4358-9A0C-FCE24CD22013

P2860

Q34077664-22A6380E-F82F-490A-A0CB-19C0EC448974

Q34077664-303BC00B-7444-4FEB-A9AD-62E22D659C3C

Q34077664-320B1A6D-E852-4E2A-A299-F26A05481628

Q34077664-3BAC3011-F213-48DB-BEF7-B92BB2E7DF77

Q34077664-46AF74AF-BE6D-4AC5-ABB2-BBA6A180E16A

Q34077664-4B403DA6-8A19-42B9-8605-D74B1283CEAC

Q34077664-4C6CD1B4-E27F-46A2-A632-AF284B35237C

Q34077664-4CC5CB5D-E3A4-4AE7-B1C2-C04A569482C3

Q34077664-4E65330B-891C-4B0C-8303-BBEAF8A8FBAF

Q34077664-54039208-D9B6-4C75-8F5D-D5C672A9E88C

P304

Q34077664-78352E19-D21C-459C-8DF5-2BD6D2BE4EEE

P31

Q34077664-4370D115-E290-411F-A289-1095744CCA22

P356

Q34077664-1134D969-3CF9-4CFF-8163-3E6A6D22520E

P407

Q34077664-CDEA9BFC-7C6A-4301-885B-B78B8696A4B0

P433

Q34077664-E9B06FAF-DD78-4211-AA79-694217108A39

P478

Q34077664-92DE0BD8-20F0-4E69-B418-C8E3CAB12BEC

P50

Q34077664-3E365251-7C3E-4F19-8B07-45C48E322079

Q34077664-6C6D0118-ADC2-404F-A854-16F482F2EC80

Q34077664-6D11B1E6-0850-4B7F-863C-BFD077E94924

Q34077664-75395869-6282-4415-86F0-5C6BFCD4075D

Q34077664-836ADF90-8EEA-4606-BDB6-40B1C31B1AC7

Q34077664-9DDF561F-9845-4099-AD73-A37BE7583FF3

Q34077664-B0BE57AE-425C-423B-92C7-D46A9BDB397D

Q34077664-C4470E82-6373-4291-9A9A-5EEF3E1D8181

Q34077664-CC8C89A1-CB96-49B5-9FC8-B3EDFA339654

P577

Q34077664-E2032365-2A64-4CA5-9C4E-6DF717CA0815

P698

Q34077664-5214C8C8-FA17-4A05-ABED-CFD0C3BF4EE9

P921

Q34077664-439C5BA5-E689-4B6F-B5D5-EC9745A5A7D0

Q34077664-44D29A38-B4E4-40AC-B56F-34822930FA83

P932

Q34077664-42E64665-C2F3-4745-96AC-8119AA60BA71

P356

QAI.0B013E3181E0C4CF

P1433

Journal of Acquired Immune Deficiency Syndromes

P1476

Early mortality and loss to fo ...... al therapy in Southern Africa.

@en

P2093

Brian Eley

http://www.w3.org/2001/XMLSchema#string

Gilles Van Cutsem

http://www.w3.org/2001/XMLSchema#string

Hans Prozesky

http://www.w3.org/2001/XMLSchema#string

International epidemiologic Databases to Evaluate AIDS in Southern Africa

http://www.w3.org/2001/XMLSchema#string

Karl Technau

http://www.w3.org/2001/XMLSchema#string

Margaret Pascoe

http://www.w3.org/2001/XMLSchema#string

Martin W G Brinkhof

http://www.w3.org/2001/XMLSchema#string

Paula Vaz

http://www.w3.org/2001/XMLSchema#string

P2860

Public-health and individual approaches to antiretroviral therapy: township South Africa and Switzerland compared

Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality

Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Côte d'Ivoire appraisal

Adherence to antiretroviral therapy in young children in Cape Town, South Africa, measured by medication return and caregiver self-report: a prospective cohort study.

Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa

Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review

Sampling-based approaches to improve estimation of mortality among patient dropouts: experience from a large PEPFAR-funded program in Western Kenya.

Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis.

Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD).

Outcomes of the South African National Antiretroviral Treatment Programme for children: the IeDEA Southern Africa collaboration.

P304

524-532

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/QAI.0B013E3181E0C4CF

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P50

Mary-Ann Davies

P577

2010-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20588185

http://www.w3.org/2001/XMLSchema#string

P921

Southern Africa

antiretroviral drug

P932

2925143

http://www.w3.org/2001/XMLSchema#string